Successful therapy of a patient with therapy recalcitrant generalized bullous scleroderma by extracorporeal photopheresis and mycophenolate mofetil

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 5, 2008, Pages 631-633

  Schlaak, Max ^a   Friedlein, H ^a   Kauer, F ^a   Renner, R ^a   Rogalski, C ^a   Simon, J C ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLOSPORIN; ETRETIN; GABAPENTIN; GLUCOCORTICOID; METHOTREXATE; MORPHINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN G;

ANALGESIA; BULLOUS SYSTEMIC SCLEROSIS; CASE REPORT; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; ELECTRON THERAPY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; LETTER; MORPHEA; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PUVA; RECURRENT DISEASE; SCAR FORMATION; SKIN ULCER; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE; ULCER HEALING; ULTRAVIOLET A RADIATION; VESICULAR RASH;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MYCOPHENOLIC ACID; PHOTOPHERESIS; SCLERODERMA, LOCALIZED;

EID: 42149110210     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02403.x     Document Type: Letter

References (8)

1. Sapadin AN, Fleischmajer R. Treatment of Scleroderma. Arch Dermatol 2002; 138: 99-105.
2. Ihn H. Pathogenesis of fibrosis: Role TGF-beta and CTGF. Curr Opin Rheumatol 2002; 14: 681-685.
3. Daoud MS, Su WP, Leiferman KM, Perniciaro C. Bullous morphea. Clinical, pathologic and immunopathologic evaluation of thirteen cases. J Am Acad Dermatol 1994; 30: 937-943.
4. Bladon J, Taylor PC. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes. Photodermatol Photoimmunol Photomed 2005; 21: 293-302.
5. Maeda A, Schwarz A, Kernebeck K et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005; 174: 5968-5976.
6. Suchin KR, Cassin M, Washko R et al. Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens. J Am Acad Dermatol 1999; 41: 980.
7. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. Tumour necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem 2000; 275: 15220-15225.
8. Ohtsuka T, Okita H, Yamakage A, Yamazaki S. The effect of extracorporeal photochemotherapy on α1(I) and α1(III) procollagen mRNA expression in systemic sclerosis skin tissue. Arch Dermatol Res 2002; 293: 642-645.